Chart-Based Visual Function Tests Limited in Detecting Intermediate AMD
June 28th 2022A noninterventional study found that chart-based assessments of visual function had adequate repeatability but were limited in discriminating between no age-related macular degeneration (AMD) and intermediate AMD.
Read More
Risk for CVD Increases Following INSTI Use for HIV
June 28th 2022A possible connection between integrase strand-transfer inhibitor (INSTI) use for HIV and cardiovascular disease (CVD) was investigated in this new study from an international team wanting more knowledge on the drug class’s treatment effects.
Read More
RSV Linked With Hospital Mortality Rates Typically Seen With the Flu
June 28th 2022Patients with respiratory syncytial virus infection (RSV) were also more likely to have underlying chronic respiratory conditions and other comorbidities, according to a recent study looking at people hospitalized in ICUs.
Read More
CMS Announces OCM Successor, but Gap Year Remains for Oncology Practices
June 27th 2022Today, CMS unveiled its plan for a successor to the Oncology Care Model (OCM), its ambitious foray into value-based care delivery that has been credited with changing the landscape for patients with cancer, even if it received mixed reviews on achieving savings in its early years.
Read More
Stakeholders Address How Digital Therapeutics Can Bridge Unmet Needs in Behavioral Health Care
June 27th 2022Two stakeholders involved in investment and development of behavioral care services discuss the potential of digital therapeutics as a cost-effective alternative to address unmet mental health needs during an AHIP 2022 session.
Read More
FMT Is Cost Effective for Any Recurrent Clostridioides Difficile Infection, Study Says
June 27th 2022Research found fecal microbiota transplantation (FMT) to be an optimal cost-effective treatment strategy for first and subsequent recurrent Clostridioides difficile infection (CDI), challenging current guidelines.
Read More
Patients With COPD Prefer Improvement of Daily Symptoms Rather Than Exacerbations
June 27th 2022A discrete choice experiment found that patients with moderate-to-severe chronic obstructive pulmonary disease (COPD) valued improvement in their daily symptoms more than improvement of exacerbations.
Read More
Exceptions for rape and incest in states with trigger laws outlawing abortion may be impossible to implement effectively; Supreme Court determines Medicare’s payments are lawful in a blow to hospitals that had pay cuts; a court ruled that Juul could continue selling e-cigarettes temporarily.
Read More
Dr Christopher Thompson Discusses GI Innovation Presented at DDW
June 27th 2022Christopher Thompson, MD, MSc, FASGE, FACG, AGAF, FJGES, director of endoscopy and codirector of the Center for Weight Management and Wellness at Brigham & Women’s Hospital, professor of medicine at Harvard Medical School, discusses a session on gastrointestinal (GI) invention at the recent conference, Digestive Disease Week, held May 21-24 in San Diego, California.
Read More
Gout Flare Likely Increases Hospital LOS in Heart Failure
June 25th 2022Using the Nationwide Inpatient Database for trends studied between 1993 and 2011, investigators from Columbia University Irving Medical Center evaluated hospitalization outcomes among patients with heart failure and comorbid gout.
Read More
Dr Robert Sidbury on Promoting Therapeutic Adherence in Pediatric Atopic Dermatitis
June 25th 2022Robert Sidbury, MD, MPH, Chief, Division of Dermatology, Seattle Children's Hospital, speaks on strategies that clinicians can employ to promote adherence of topical and oral medications in pediatric patients with atopic dermatitis.
Watch
Interim Phase 2 Trial Results Show Quadruplet Regimen Tolerable, Effective in MM
June 25th 2022Early results of a multicenter phase 2 trial exploring the efficacy of daratumumab, pomalidomide, dexamethasone, and ixazomib treatment suggest the regimen is safe and effective in relapsed or refractory multiple myeloma (MM).
Read More
Influenza and PPSV23 Vaccines Evaluated for Their Ability to Stem COPD Exacerbations
June 25th 2022A cohort study found that influenza and 23-valent pneumococcal polysaccharide vaccines (PPSV23) can reduce the risk of chronic obstructive pulmonary disease (COPD)- and pneumonia-related hospitalizations.
Read More
Researchers Outline Use of Hormonal Therapies in Acne, Hidradenitis Suppurativa
June 25th 2022Combined oral contraceptives (COCs) and, more recently, spironolactone, have been identified as options for adolescent females with acne and hidradenitis suppurativa (HS), although varying levels of data are available supporting their use in these patients.
Read More
Study Finds Environmental, Lifestyle Risk Factors of Atopic Dermatitis in Preschool Children
June 24th 2022Several environmental and lifestyle factors were associated with significant risk of atopic dermatitis development in preschool children of Shenzhen, China, including the presence of mold in the child’s room, living in a villa/townhouse, and using composite wood floors.
Read More
Dr Christopher Thompson Discusses Innovative Treatment for Type 2 Diabetes and Obesity
June 24th 2022Christopher Thompson, MD, MSc, FASGE, FACG, AGAF, FJGES, director of endoscopy and codirector of the Center for Weight Management and Wellness at Brigham & Women’s Hospital, professor of medicine at Harvard Medical School, discusses duodenal jejunal bypass liner treatment and future innovations in gastroenterology.
Read More
Identifying Consistent Characteristics Among Patients With Refractory, Unexplained Chronic Cough
June 24th 2022Individuals with refractory or unexplained chronic cough had characteristics consistent of those with chronic cough in general, including cough duration, severity, and 24-hour frequency.
Read More
What’s Next in Health Care? Panelists Highlight Data, Partnerships Post-COVID-19
June 24th 2022Panelists of an AHIP 2022 session discussed how future policy, infrastructure, and investment strategies in public health will reinforce the efforts already made during the pandemic, with partnerships and engagement key to optimize innovation.
Read More
Switching Among Infliximab Biosimilars Effective and Well Tolerated, Research Finds
June 24th 2022Among a real-world cohort of patients, switching between infliximab biosimilars was effective and well tolerated, although retention was higher among those who had initially started on the originator product.
Read More